These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34098125)

  • 1. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction.
    Jayaraj A; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):325-333.e1. PubMed ID: 34358674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of native iliac vein aspect ratio on initial clinical presentation and outcomes following stenting for symptomatic chronic iliofemoral venous obstruction.
    Butts H; Jayaraj A
    J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101900. PubMed ID: 38677552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes.
    Jayaraj A; Thaggard D; Lucas M
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):634-641. PubMed ID: 36731654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a dedicated venous stent and standard composite Wallstent-Z stent approach to iliofemoral venous stenting: Intermediate-term outcomes.
    Powell T; Raju S; Jayaraj A
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):82-90.e2. PubMed ID: 35872144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial role of complex decongestive therapy in patients with symptomatic chronic iliofemoral venous obstruction with phlebolymphedema.
    Jayaraj A; Thaggard D
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101686. PubMed ID: 37714459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction.
    Jayaraj A; Fuller R; Raju S; Stafford J
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):42-51. PubMed ID: 34174500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
    Jayaraj A; Noel C; Kuykendall R; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
    Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
    J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting.
    Jayaraj A; Buck W; Knight A; Johns B; Raju S
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):195-202. PubMed ID: 30553783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.
    Gagne PJ; Gasparis A; Black S; Thorpe P; Passman M; Vedantham S; Marston W; Iafrati M
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):48-56.e1. PubMed ID: 29033314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral limb improvement after unilateral iliac vein stenting argues against simultaneous bilateral stenting.
    Jayaraj A; Noel C; Raju S
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):565-571. PubMed ID: 32381472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Femoral Vein Obstruction Concomitant with Iliofemoral Stenting in Patients with Severe Post-thrombotic Syndrome.
    Ye K; Shi H; Yin M; Qin J; Yang X; Liu X; Jiang M; Lu X
    Eur J Vasc Endovasc Surg; 2018 Feb; 55(2):222-228. PubMed ID: 29292209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional computed tomography venogram enables accurate diagnosis and treatment of patients presenting with symptomatic chronic iliofemoral venous obstruction.
    Jayaraj A; Raju S
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):73-80.e1. PubMed ID: 32800980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement following restoration of inline flow argues against comprehensive thrombus removal strategies and for selective stenting in acute symptomatic iliofemoral venous thrombosis.
    Jayaraj A; Lucas M; Fuller R; Powell T; Kuykendall R
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):119-126. PubMed ID: 35952953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous stent patency is independent of total stented length in nonthrombotic iliac vein and post-thrombotic venous stenoses.
    Robertson B; Shapiro J; Muck A; Fellner AN; Recht M; Kulwicki A; Broering M; Kuhn B; Muck P
    J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):339-345. PubMed ID: 36007799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iliofemoral venous stenting in patients with central neuromuscular disorders.
    Saleem T; Powell T; Raju S
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):626-632. PubMed ID: 34695594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study).
    Hofmann LR; Gagne P; Brown JA; Saunders A; Comerota A;
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):532-541.e4. PubMed ID: 36646383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
    Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
    Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected major role for venous stenting in deep reflux disease.
    Raju S; Darcey R; Neglén P
    J Vasc Surg; 2010 Feb; 51(2):401-8; discussion 408. PubMed ID: 20006920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.